Physician

Neharika Bhardwaj, MD

According to 2025 Medicare claims, Neharika Bhardwaj, MD (NPI: 1336609494) practices rheumatology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is THAILA RAMANUJAM M D INC (NPI: 1700056280; TIN: 26-1825888) and primary practice location at 93940-2909. Bhardwaj is affiliated with the Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Bhardwaj's data goes back to 2015 and runs through 2024. Part D data shows 270 prescription claims across 54 beneficiaries totaling $226,787 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 6 records totaling $387. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,286 to $226,787. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	24	62	$3,286
2020	54	122	$8,782
2021	39	166	$42,771
2022	53	248	$26,874
2023	61	170	$42,730
2024	54	270	$226,787

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	14	392	$139,997
Mycophenolate Mofetil	Mycophenolate Mofetil	17	536	$2,294
Colchicine	Colchicine	13	774	$1,467
Allopurinol	Allopurinol	25	1,620	$845
Celecoxib	Celecoxib	18	810	$832

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$387	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Neharika Bhardwaj, MD?

Tedicare shows public-source Medicare data for Neharika Bhardwaj, MD (NPI 1336609494), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neharika Bhardwaj, MD have ACO affiliation data?

Neharika Bhardwaj, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Neharika Bhardwaj, MD?

Neharika Bhardwaj, MD is linked to THAILA RAMANUJAM M D INC (billing NPI 1700056280) in the available physician profile data.

Does Neharika Bhardwaj, MD have Open Payments data?

Neharika Bhardwaj, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.